NEWS RELEASE: Saskatchewan and Manitoba Partner on MS Liberation Clinical Trial Research
April 21, 2011
The Province of Manitoba has announced it will work with Saskatchewan to advance clinical trial research on the MS liberation therapy.
Manitoba will invest $5 million in MS research and follow the Saskatchewan Health Research Foundation (SHRF) protocols in a complementary research process in Manitoba.
Saskatchewan was the first province to initiate clinical trials for the MS liberation procedure when it announced a $5-million investment and launched a call for proposals in December 2010. SHRF is managing the publicly funded health research process, and has developed a competitive call for clinical trials and appointed an expert advisory panel. A research proposal that will lead to clinical trials will be selected soon.
“MS patients and their families deserve to know as quickly as possible whether this experimental procedure is the breakthrough so many of us hope it is,” said Premier Greg Selinger. “This partnership will help us get the answers we urgently need while providing Manitobans a chance to participate early in the clinical trial process.”
The liberation procedure is a potentially ground-breaking discovery for the treatment of MS. However, it is not yet proven as a scientifically valid therapy.
The Province says patients in both provinces will have an opportunity to participate in the clinical trials once successful research teams have been announced. More information on research processes in Saskatchewan and Manitoba is available at www.shrf.ca and www.mhrc.mb.ca.
Read the full news release here.
Read More News Stories